Preparation and immunogenicity of gold glyco-nanoparticles as antipneumococcal vaccine modelShow others and affiliations
2017 (English)In: Nanomedicine, ISSN 1743-5889, E-ISSN 1748-6963, Vol. 12, no 1, p. 13-23Article in journal (Refereed) Published
Abstract [en]
Aim: Nanotechnology-based fully synthetic carbohydrate vaccines are promising alternatives to classic polysaccharide/protein conjugate vaccines. We have prepared gold glyco-nanoparticles (GNP) bearing two synthetic carbohydrate antigens related to serotypes 19F and 14 of Streptococcus pneumoniae and evaluated their immunogenicity in vivo. Results: A tetrasaccharide fragment of serotype 14 (Tetra-14), a trisaccharide fragment of serotype 19F (Tri-19F), a T-helper peptide and D-glucose were loaded onto GNP in different ratios. Mice immunization showed that the concomitant presence of Tri-19F and Tetra-14 on the same nanoparticle critically enhanced the titers of specific IgG antibodies toward type 14 polysaccharide compared with GNP exclusively displaying Tetra-14, while no IgG antibodies against type 19F polysaccharide were elicited. Conclusion: This work is a step forward toward synthetic nanosystems combining carbohydrate antigens and immunogenic peptides as potential carbohydrate-based vaccines.
Place, publisher, year, edition, pages
Future Medicine Ltd , 2017. Vol. 12, no 1, p. 13-23
Keywords [en]
capsular polysaccharide fragments, carbohydrate-based vaccines, gold glyco-nanoparticles, immunogenicity, Streptococcus pneumoniae
National Category
Infectious Medicine
Identifiers
URN: urn:nbn:se:kth:diva-305695DOI: 10.2217/nnm-2016-0306ISI: 000395673300004PubMedID: 27879152Scopus ID: 2-s2.0-85002706606OAI: oai:DiVA.org:kth-305695DiVA, id: diva2:1617266
Note
QC 20211206
2021-12-062021-12-062022-06-25Bibliographically approved